MoneyWorks4Me

Mankind Pharma - Quaterly Results

31 Oct 2023 Evaluate
The company witnessed a 8.67% growth in the revenue at Rs. 24533.45 millions for the quarter ended September 2023 as compared to Rs. 22575.49 millions during the year-ago period.A humble growth in net profit of 12.53% reported in the quarter ended September 2023 to Rs. 4728.85  millions from Rs. 4202.32 millions.Operating profit for the quarter ended September 2023 rose to 6933.12 millions as compared to 5914.84 millions of corresponding quarter ended September 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 24533.45 22575.49 8.67 47535.56 43188.00 10.07 81271.53 74862.22 8.56
Other Income 581.18 691.47 -15.95 1155.54 879.23 31.43 1627.83 2038.14 -20.13
PBIDT 6933.12 5914.84 17.22 12902.17 10306.45 25.19 18601.64 20418.85 -8.90
Interest 43.10 81.90 -47.37 62.78 176.19 -64.37 277.48 471.21 -41.11
PBDT 6890.02 5832.94 18.12 12839.39 10130.26 26.74 18324.16 19947.64 -8.14
Depreciation 770.39 660.40 16.66 1455.82 1312.61 10.91 2695.80 1233.27 118.59
PBT 6119.63 5172.54 18.31 11383.57 8817.65 29.10 15628.36 18714.37 -16.49
TAX 1390.78 970.22 43.35 2561.89 1633.69 56.82 3145.79 4820.13 -34.74
Deferred Tax 168.24 77.75 116.39 246.97 196.68 25.57 229.43 529.79 -56.69
PAT 4728.85 4202.32 12.53 8821.68 7183.96 22.80 12482.57 13894.24 -10.16
Equity 400.59 400.59 0.00 400.59 400.59 0.00 400.59 400.59 0.00
PBIDTM(%) 28.26 26.20 7.86 27.14 23.86 13.74 22.89 27.28 -16.08
Peers
Company Name CMP
Sun Pharma. Inds. 1844.00
Dr. Reddys Labs. 1212.00
Cipla 1381.00
Lupin 2120.10
Zydus Lifesciences 1161.00
View more..